3Bleiberg H. Oxaliplatin (L-OHP): a new reality in colorectal cancer [J]. BrJ Cancer, 1998, 77 (Supple 4):1-3.
4Louvet C, de Gramont A. Place et interet Ⅰ' oxaliplatine dans les cancers colorectaux metastases [J]. Rev Med Interne, 1997, 18(Suppl 4) :368s - 371s.
5Maindrault-Goebel F, de Gramont A, Louvet C, et al. High-dose intencity Oxaliplatin added to the simplified bimonthly leuovorin and 5-flourouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX7) [J]. Eur J Cancer, 2001,37(8):1000- 1005.
6Maindrault-Goebel F, Louvet C, Andre J, et al. Oxaliplatin Added to the Simplified Bimonthly Leucovorin and 5-Flourouracil Regimen as Second-line Therapy for Metastatio Colorectal Cancer (FOLFOX6) [J]. Eur J Cancer, 1999, 35(9):1338-1342.
7De Gramont A, Krulik M, Cady J, et al. High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer.Eur J Cancer Clin Oncol, 1988, 24:1499-1503.
8Ajani JA. Current status of therapy for advanced gastric carcinoma.Oncology, 1998, 12:99-102.
9Raymond E, Charley SG, Taamma A, et al. Oxaliplatin: a review of preclinical and clinical studies. Ann Oncol, 1998, 9:1053-1071.
10De Gramont A, Figer A, Seymonr M, et al. Leucovorin and fluorouracil with or without oxaliplatin as frist-line treatment in advanced colorectal cancer. J Clin Oncol, 2000,18:2938-2947.
9Mohammad H A,Magdy F M,Mahmoud O M.FOLFOX (oxaliplatin and 5 fluorouracil/leucovorin) in patients with untreated metastatic gastric adenocarcinoma Phase Ⅱ study[J].Indian J Cancer,2011,48(4):460-465.
